$3.11
0.175.78%
At close: Aug 20, 5:00 PM EST
$3.07
0.134.43%
Pre-Market: 8:35 AM EST
Editas Medicine Inc Earnings Estimates
EDITNASDAQ
Editas Medicine Earnings Estimates, EPS & Revenue | NASDAQ:EDIT
Editas Medicine (EDIT) is scheduled to report Q3 earnings on November 9, 2026. Analysts estimate EPS of $-0.21 and quarterly revenue of $3.95M.
In the most recent quarter (Q2), Editas Medicine reported EPS of $-0.15, beating estimates of $-0.28 by 0.46%. Revenue came in at $11.9M, exceeding the estimate of $2.58M by 3.61%.
Over the last 4 quarters, Editas Medicine has averaged an EPS surprise of 0.38% and a revenue surprise of 1.85%.
Earnings Date
Nov 9
EPS Estimate
$-0.210
Quarterly Revenue Estimate
$3.95M
Annual Revenue
$47.01M
as of Jun 30
Editas Medicine Earnings History
Analyze the earnings history of Editas Medicine using advanced sorting and filters.
Editas Medicine (EDIT) Earnings Per Share
The chart below shows Editas Medicine's reported EPS compared to analyst estimates over recent quarters.
Editas Medicine (EDIT) Revenue
The chart below shows Editas Medicine's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Editas Medicine (NASDAQ:EDIT) reporting earnings?
Editas Medicine (EDIT) is scheduled to report earnings on November 9, 2026. The last reported earnings were for reported on August 5, 2026 for Q2.
What were the latest earnings per share (EPS) for Editas Medicine (NASDAQ:EDIT)?
The Actual EPS was $-0.15, which beat the estimate of $-0.28.
What were Editas Medicine’s (NASDAQ:EDIT) revenues?
The Actual Revenue was $11.9M, which beat the estimate of $2.58M.
